Bharat Electronics (BEL) and Israel Aerospace Industries (IAI) have received approval from the Ministry of Corporate Affairs to incorporate their joint venture company, BEL, IAI AeroSystems Private Limited. The approval came on September 25, 2024. Punjab National Bank (PNB) has raised Rs 5,000 crore through a Qualified Institutions Placement (QIP).
The bank’s board approved the allotment of 48,19,27,710 equity shares to eligible qualified institutional buyers at an issue price of Rs 103.75 per share. The US Food and Drug Administration (FDA) has completed an inspection at Biocon Biologics’ insulins facility in Johor Bahru, Malaysia. The inspection concluded with no observations related to data integrity, systemic deficiencies, or quality oversight at any of the units.
Radico Khaitan, one of India’s largest IMFL companies, has officially unveiled the newest expression of its Rampur Indian Single Malt Whisky, the Barrel Blush, at Whisky Live Paris 2024. Reliance Industries Limited (RIL) and Disney have announced a strategic joint venture to bring together the most compelling and engaging entertainment brands in India.
bel partners with iai for venture
The Ministry of Information and Broadcasting has approved the transfer of licenses relating to non-news & current affairs TV channels held by Viacom18 Media Private Ltd in favor of Star India Private Ltd, subject to conditions laid by the Competition Commission of India. Tata Motors has conducted a ground-breaking ceremony for its new vehicle manufacturing facility in Tamil Nadu. The state-of-the-art plant will use 100% renewable power to produce next-gen vehicles for Indian and global markets and will create over 5,000 employment opportunities locally.
Lupin, the Mumbai-based drug maker, has informed exchanges that the US FDA inspected its Pithampur Unit-1 API and finished product manufacturing facility from September 16 to September 27, 2024. The inspection concluded with three observations each on the API and finished product side. Zydus Lifesciences has received final approval from the US FDA to manufacture Enzalutamide Capsules, 40 mg.
These capsules are indicated for the treatment of patients with metastatic castration-resistant prostate cancer and will be produced at the group’s manufacturing site in Moraiya, Ahmedabad. HDFC Life Insurance Company Ltd is raising funds through the issuance of subordinated debt instruments in the form of non-convertible debentures up to Rs 2,000 crore. Life Insurance Corporation of India (LIC) has decreased its shareholding in Mahanagar Gas from 9.030% to 6.939%.
